Sartorius Aktiengesellschaft (OTCMKTS:SUVPF – Get Free Report) is projected to announce its resultson Thursday, July 23rd. Analysts expect the company to announce earnings of $1.55 per share and revenue of $1.0669 billion for the quarter.
Sartorius Aktiengesellschaft Stock Performance
SUVPF opened at $256.25 on Wednesday. The business has a fifty day moving average of $258.10 and a 200 day moving average of $267.62. Sartorius Aktiengesellschaft has a 52-week low of $208.00 and a 52-week high of $312.93.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft is a global life science and laboratory equipment supplier headquartered in Göttingen, Germany. The company designs, manufactures and markets instruments and consumables that support research, development and production of biopharmaceuticals, vaccines and other high-value biologics. Its customer base spans academic and governmental research institutions as well as pharmaceutical and biotechnology firms.
Operations are structured into two core segments: Bioprocess Solutions and Lab Products & Services.
Recommended Stories
- Five stocks we like better than Sartorius Aktiengesellschaft
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
